Method for assaying endotoxin in a whole blood sample or protein solution containing the same

• US 5,286,625 A
• Filed: 11/08/1991
• Issued: 02/15/1994
• Est. Priority Date: 08/22/1990
• Status: Expired due to Term

• Current Assignee: Seikagaku Kogyo Kabushiki Kaisha
• Original Assignee: Seikagaku Corporation
• Inventors: Tanaka, Shigenori, Tamura, Hiroshi
• Primary Examiner(s): Wityshyn, Michael G.
• Assistant Examiner(s): GITOMER, RALPH J
• Application Number:
  US07/789,583
• Time in Patent Office: 830 Days
• Field of Search: 435/18, 435/4, 435/23, 435/24, 436/175
• US Class Current: 435/18
• CPC Class Codes: G01N 33/579 involving limulus lysate
• CPC Class Codes: Y10T 436/25125 Digestion or removing interfering materials

Abstract

A method of assaying an endotoxin using the limulus amebocyte lysate component which comprises pretreating whole blood with nitric acid and a surfactant selected from among polyoxyethylene ethers represented by the following formula: ##STR1## wherein n is an integer of from 8 to 40; or: ##STR2## polyoxyethylene sorbitans, n-alkylglucopyranosides, sodium dodecylsulfate and lithium dodecylsulfate, which enables an efficient and accuate assay of an endotoxin.

Claims

1. A method of assaying an endotoxin in a whole blood sample or a protein solution containing a whole blood sample, using a limulus amebocyte lysate component comprising the steps of:

(a) obtaining a whole blood sample or a protein solution comprising a whole blood sample;

(b) treating said sample or solution, prior to contacting with the limulus amebocyte lysate component, by incubating said sample or solution in the presence of both nitric acid and a surfactant, separating the resulting precipitate, and collecting the supernatant, wherein the surfactant is selected from the group consisting of polyethylene glycol mono-p-iso-octylphenyl ether, polyethylene glycol mono-p-tert-octylphenoxypolyethoxyethanol, polyethylene glycol mono(nonylphenyl) ether, polyoxyethylene sorbitan monolaurate, polyoxyethylene sorbitan monopalmitate, polyoxyethylene sorbitan monostearate, polyoxyethylene sorbitan monooleate, polyoxyethylene sorbitan trioleate, n-octyl-α

-D-glucopyranoside, n-octyl-β

-D-glucopyranoside, n-nonyl-α

-D-glucopyranoside, n-nonyl-β

-D-glucopyranoside n-dodecyl-α

-D-glucopyranoside, n-dodecyl-β

-D-glucopyranoside, n-decyl-α

-D-glucopyranoside, n-decyl-β

-D-glucopyranoside, n-heptyl-α

-D-glucopyranoside, n-heptyl-β

-D-glucopyranoside, sodium dodecylsulfate and lithium dodecylsulfate; and

(c) assaying for endotoxin using the resulting treated sample or solution and the limulus amebocyte lysate component.

2. The method of assaying an endotoxin as claimed in claim 1, wherein nitric acid is used in a concentration of 0.28 to 0.83 mol/l.

3. The method of assaying an endotoxin as claimed in claim 1, wherein the treatment of the sample or solution with nitric acid and a surfactant, prior to contacting with the limulus amebocyte lysate component, is carried out at 25°

to 70°

C.

4. The method of assaying an endotoxin as claimed in claim 1, wherein the treatment of the sample or solution with nitric acid and a surfactant, prior to contacting with the limulus amebocyte lysate component, is carried out for 3 to 30 minutes.

5. The method of assaying an endotoxin as claimed in claim 1, wherein the whole blood sample is selected from the group consisting of human, bovine, equine, canine, sheep, goat, rabbit, rat, guinea pig and mouse blood.

6. The method of assaying an endotoxin as claimed in claim 1, wherein the sample or solution is treated with the surfactant and then with nitric acid.

7. The method of assaying an endotoxin as claimed in claim 1, wherein the sample or solution is treated with the surfactant and nitric acid simultaneously.

8. The method of assaying an endotoxin as claimed in claim 1, wherein the sample or solution is treated with a nitric acid solution containing the surfactant.